- Investing Ideas
- /
- Canadian Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Canadian Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Results
3
1 new
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
3 companies
Green Thumb Industries
Market Cap: CA$2.2b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
New
GTII
CA$9.62
7D
17.6%
1Y
-39.6%
Grown Rogue International
Market Cap: CA$134.7m
A craft cannabis company, focuses on premium flower and flower-derived products.
GRIN
CA$0.55
7D
-3.5%
1Y
-37.5%
FinCanna Capital
Market Cap: CA$5.0m
Does not have significant operations.
CALI.X
CA$0.005
7D
0%
1Y
n/a